loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 206619 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ABBVIE (1)

filter

01 TABLET;ORAL (1)

filter

01 DISCN (1)

filter

01 VIEKIRA PAK (COPACKAGED) (1)

filter

01 Yes (1)

URL Supplier Web Content
TABLET; ORAL
EQ 250MG BASE;12.5...
2014-12-19
206619
VIEKIRA PAK (COPAC...
DISCN
Yes
Abbvie Company Banner

Chinaplas 2024

Not Confirmed

envelop Contact Supplier

Looking for FDA Orange Book APPLICATION 206619

Looking for FDA Orange Book APPLICATION 206619 1

19

AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR, with a corresponding application number 206619.

Regulatory Information DISCN

With a dosage strength EQ 250MG BASE;12.5MG, 75MG, 50MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2014-12-19

Post Enquiry
POST ENQUIRY